A focused product portfolio
Specialist pharmaceuticals including CNS and Oncology represent the biggest individual segments within the current pharmaceutical industry pipeline. They also have great future potential with many patient needs still to be met.
We have a fast-growing porfolio of products, the most significant of which are:
Gelclair
Xenazine
ImmuCyst 81mg
Research and development is also a significant and growing area of our activities. We work with leading clinical research organisations (CROs) who provide chemistry capabilities for the identification, metabolism and synthesis of pharmaceutical compounds. We in turn have the ability to investigate market potential and intellectual property opportunities that reside within such discoveries.